Suven Pharmaceuticals Limited Sustainability Profile
Suven Pharmaceuticals Limited, a prominent player in the pharmaceutical industry, is headquartered in Hyderabad, India. Founded in 1989, the company has established itself as a leader in the development of innovative drug discovery and development services, particularly in the fields of central nervous system disorders and other therapeutic areas. With a strong focus on research and development, Suven Pharmaceuticals offers a diverse portfolio of products, including proprietary drug candidates and contract research services. The company is recognised for its unique approach to drug development, leveraging advanced technologies to enhance therapeutic efficacy. Suven's commitment to quality and innovation has positioned it favourably in the global market, earning accolades for its contributions to healthcare and significant milestones in clinical research. As it continues to expand its operational footprint, Suven Pharmaceuticals remains dedicated to improving patient outcomes through cutting-edge pharmaceutical solutions.
DitchCarbon Score
How does Suven Pharmaceuticals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Suven Pharmaceuticals Limited's score of 58 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Suven Pharmaceuticals Limited's reported carbon emissions
In 2024, Suven Pharmaceuticals Limited reported total carbon emissions of approximately 41,183,000 kg CO2e for Scope 1 and about 22,941,000 kg CO2e for Scope 2. This represents a slight decrease from 2023, where emissions were approximately 48,594,000 kg CO2e for Scope 1 and about 33,723,000 kg CO2e for Scope 2. The company has set ambitious climate commitments, aiming for a 15% reduction in CO2 emissions per metric ton produced for both Scope 1 and Scope 2 by 2025, starting from 2023 levels. Long-term targets include a significant reduction of 90% in absolute Scope 1 and Scope 2 emissions by 2050, with a similar target for Scope 3 emissions. Near-term goals also include a 54.6% reduction in absolute emissions across all scopes by 2033, using 2023 as the base year. These targets are aligned with the Science Based Targets initiative (SBTi) and are designed to keep global warming below 1.5°C. Suven Pharmaceuticals Limited's commitment to achieving net-zero greenhouse gas emissions across its value chain by 2050 underscores its dedication to sustainability and climate action. The emissions data and reduction targets are cascaded from the parent organization, ensuring a cohesive approach to environmental responsibility within the corporate family.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 47,497,790 | 00,000,000 | 00,000,000 |
| Scope 2 | 35,462,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
How Carbon Intensive is Suven Pharmaceuticals Limited's Industry?
How Carbon Intensive is Suven Pharmaceuticals Limited's Location?
Suven Pharmaceuticals Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Suven Pharmaceuticals Limited has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Akums Drugs and Pharmaceuticals Limited
Frequently Asked Questions
Common questions about Suven Pharmaceuticals Limited's sustainability data and climate commitments